EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)

EGX:NIPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	125.73	90.23	119.21	89.67	64.42
Depreciation & Amortization	28.57	-	330.18	-	-
Other Operating Activities	-153.36	173.89	-705.83	-84.76	15.05
Operating Cash Flow	0.93	264.11	-256.43	4.91	79.47
Operating Cash Flow Growth	-99.65%	-	-	-93.82%	60.02%
Capital Expenditures	-473.89	-419.69	-27.63	-48.74	-4.38
Sale of Property, Plant & Equipment	-	-	-	0.62	-
Other Investing Activities	0.13	0.1	0.12	0.12	0.09
Investing Cash Flow	-473.76	-419.58	-27.52	-48	-4.29
Short-Term Debt Issued	415.48	92.37	135.02	20.68	0.37
Long-Term Debt Issued	201.95	304.77	179.22	-	-
Total Debt Issued	617.43	397.14	314.23	20.68	0.37
Long-Term Debt Repaid	-186.01	-29.4	-121.1	-	-
Net Debt Issued (Repaid)	431.42	367.74	193.13	20.68	0.37
Issuance of Common Stock	77.83	-	-	-	-
Common Dividends Paid	-49.55	-64.38	-41.66	-33.3	-45.57
Other Financing Activities	-	-	121.1	-	-
Financing Cash Flow	459.7	303.36	272.57	-12.62	-45.2
Net Cash Flow	-13.12	147.89	-11.38	-55.71	29.99
Free Cash Flow	-472.96	-155.57	-284.07	-43.83	75.09
Free Cash Flow Growth	-	-	-	-	68.64%
Free Cash Flow Margin	-36.68%	-13.62%	-28.26%	-5.00%	9.94%
Free Cash Flow Per Share	-15.77	-15.37	-28.06	-4.33	7.42
Cash Interest Paid	99.77	52.98	27.16	2.89	3.18
Cash Income Tax Paid	4.09	17.13	69.42	45.08	32.77
Levered Free Cash Flow	-512.55	-232.04	189.36	-77.9	39.66
Unlevered Free Cash Flow	-468.67	-216.22	197.94	-75.92	41.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.